Lexicon Pharmaceuticals (LXRX) Non Operating Investment Income (2010 - 2022)
Lexicon Pharmaceuticals (LXRX) reported Non Operating Investment Income of -$27000.0 for Q1 2022, down 150.94% quarter-over-quarter from $53000.0 in Q2 2010.
Lexicon Pharmaceuticals (LXRX) Non Operating Investment Income (2010 - 2022) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 2 years of Non Operating Investment Income data on file, last reported at -$27000.0 in Q1 2022.
- Non Operating Investment Income for Q1 2022 came in at -$27000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was -$27000.0 (changed N/A YoY), and the FY2010 annual result was $141000.0, down 87.98% from the prior year.
- Non Operating Investment Income fell to -$27000.0 in Q1 2022 per LXRX's latest filing, from $53000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at -$27000.0 in Q1 2022 and troughed at -$27000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -27,000.00 |
| Mar 31, 2022 | -27,000.00 |
| Jun 30, 2010 | 53,000.00 |
| Jun 30, 2010 | 53,000.00 |